Identification of potential biomarkers and therapeutic targets for liver cirrhosis based on Mendelian randomization and machine learning
{{output}}
Background: Liver cirrhosis(LC) represents the end stage of chronic liver disease, yet reliable molecular markers remain limited. This study aimed to uncover potential diagnostic biomarkers and therapeutic targets for LC. ... ...
